1.Cotinine-conjugated aptamer/anti-cotinine antibody complexes as a novel affinity unit for use in biological assays.
Sunyoung PARK ; Dobin HWANG ; Junho CHUNG
Experimental & Molecular Medicine 2012;44(9):554-561
Aptamers are synthetic, relatively short (e.g., 20-80 bases) RNA or ssDNA oligonucleotides that can bind targets with high affinity and specificity, similar to antibodies, because they can fold into unique, three-dimensional shapes. For use in various assays and experiments, aptamers have been conjugated with biotin or digoxigenin to form complexes with avidin or anti-digoxigenin antibodies, respectively. In this study, we developed a method to label the 5' ends of aptamers with cotinine, which allows formation of a stable complex with anti-cotinine antibodies for the purpose of providing another affinity unit for the application in biological assays using aptamers. To demonstrate the functionality of this affinity unit in biological assays, we utilized two well-known aptamers: AS1411, which binds nucleolin, and pegaptanib, which binds vascular endothelial growth factor. Cotinine-conjugated AS1411/anti-cotinine antibody complexes were successfully applied to immunoblot, immunoprecipitation, and flow cytometric analyses, and cotinine-conjugated pegaptanib/anti-cotinine antibody complexes were used successfully in enzyme immunoassays. Our results show that cotinine-conjugated aptamer/anti-cotinine antibody complexes are an effective alternative and complementary technique for aptamer use in multiple assays and experiments.
Animals
;
Antibodies, Anti-Idiotypic/immunology/metabolism
;
*Aptamers, Nucleotide/chemistry/immunology
;
Biological Assay
;
*Cotinine/administration & dosage/chemistry
;
Flow Cytometry
;
Hep G2 Cells
;
Humans
;
Mice
;
NIH 3T3 Cells
;
Phosphoproteins/*chemistry/immunology
;
Protein Binding
;
RNA-Binding Proteins/*chemistry/immunology
;
*Vascular Endothelial Growth Factor A/chemistry/immunology
2.Binding of bacterial secondary messenger molecule c di-GMP is a STING operation.
Neil SHAW ; Songying OUYANG ; Zhi-Jie LIU
Protein & Cell 2013;4(2):117-129
Initial skirmishes between the host and pathogen result in spillage of the contents of the bacterial cell. Amongst the spillage, the secondary messenger molecule, cyclic dimeric guanosine monophosphate (c di-GMP), was recently shown to be bound by stimulator of interferon genes (STING). Binding of c di-GMP by STING activates the Tank Binding Kinase (TBK1) mediated signaling cascades that galvanize the body's defenses for elimination of the pathogen. In addition to c di-GMP, STING has also been shown to function in innate immune responses against pathogen associated molecular patterns (PAMPs) originating from the DNA or RNA of pathogens. The pivotal role of STING in host defense is exemplified by the fact that STING(-/-) mice die upon infection by HSV-1. Thus, STING plays an essential role in innate immune responses against pathogens. This opens up an exciting possibility of targeting STING for development of adjuvant therapies to boost the immune defenses against invading microbes. Similarly, STING could be targeted for mitigating the inflammatory responses augmented by the innate immune system. This review summarizes and updates our current understanding of the role of STING in innate immune responses and discusses the future challenges in delineating the mechanism of STING-mediated responses.
Animals
;
Cyclic GMP
;
physiology
;
Dimerization
;
Herpes Simplex
;
immunology
;
pathology
;
Humans
;
Immunity, Innate
;
Membrane Proteins
;
chemistry
;
genetics
;
metabolism
;
Protein Binding
;
RNA, Viral
;
metabolism
;
STAT6 Transcription Factor
;
metabolism
;
Second Messenger Systems
3.SUMOylation of RIG-I positively regulates the type I interferon signaling.
Zhiqiang MI ; Jihuan FU ; Yanbao XIONG ; Hong TANG
Protein & Cell 2010;1(3):275-283
Retinoic acid-inducible gene-I (RIG-I) functions as an intracellular pattern recognition receptor (PRR) that recognizes the 5'-triphosphate moiety of single-stranded RNA viruses to initiate the innate immune response. Previous studies have shown that Lys63-linked ubiquitylation is required for RIG-I activation and the downstream anti-viral type I interferon (IFN-I) induction. Herein we reported that, RIG-I was also modified by small ubiquitin-like modifier-1 (SUMO-1). Functional analysis showed that RIG-I SUMOylation enhanced IFN-I production through increased ubiquitylation and the interaction with its downstream adaptor molecule Cardif. Our results therefore suggested that SUMOylation might serve as an additional regulatory tier for RIG-I activation and IFN-I signaling.
Adaptor Proteins, Signal Transducing
;
physiology
;
Base Sequence
;
Binding Sites
;
DEAD Box Protein 58
;
DEAD-box RNA Helicases
;
chemistry
;
genetics
;
immunology
;
physiology
;
DNA Primers
;
genetics
;
Gene Knockdown Techniques
;
HEK293 Cells
;
HeLa Cells
;
Humans
;
Immunity, Innate
;
Interferon Type I
;
immunology
;
physiology
;
RNA Interference
;
SUMO-1 Protein
;
physiology
;
Sendai virus
;
immunology
;
Signal Transduction
;
Sumoylation
;
Ubiquitin-Conjugating Enzymes
;
antagonists & inhibitors
;
genetics
;
physiology